ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 778 filers reported holding ASTRAZENECA PLC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,678,716 | +4.3% | 216,756 | +10.2% | 0.13% | +14.5% |
| Q2 2023 | $14,075,671 | -0.3% | 196,670 | -3.3% | 0.11% | -7.6% |
| Q1 2023 | $14,116,815 | +5.4% | 203,383 | +2.9% | 0.12% | +0.8% |
| Q4 2022 | $13,394,365 | +6.2% | 197,557 | -14.1% | 0.12% | +2.6% |
| Q3 2022 | $12,608,000 | -19.8% | 229,894 | -3.4% | 0.12% | -7.3% |
| Q2 2022 | $15,726,000 | -11.5% | 238,030 | -11.1% | 0.12% | +15.9% |
| Q1 2022 | $17,770,000 | +9.5% | 267,852 | -3.9% | 0.11% | +25.9% |
| Q4 2021 | $16,229,000 | -21.9% | 278,607 | -19.4% | 0.08% | -32.0% |
| Q3 2021 | $20,767,000 | +635.1% | 345,771 | +632.9% | 0.12% | +635.3% |
| Q2 2021 | $2,825,000 | +25.0% | 47,176 | +3.8% | 0.02% | +13.3% |
| Q1 2021 | $2,260,000 | +20.2% | 45,450 | +20.9% | 0.02% | +25.0% |
| Q4 2020 | $1,880,000 | +62.5% | 37,603 | +78.1% | 0.01% | +50.0% |
| Q3 2020 | $1,157,000 | -18.5% | 21,111 | -21.3% | 0.01% | -27.3% |
| Q2 2020 | $1,420,000 | +47.2% | 26,837 | +24.1% | 0.01% | +10.0% |
| Q1 2020 | $965,000 | -24.6% | 21,626 | -15.8% | 0.01% | 0.0% |
| Q4 2019 | $1,280,000 | +13.4% | 25,688 | +1.5% | 0.01% | +11.1% |
| Q3 2019 | $1,129,000 | -28.5% | 25,318 | -33.8% | 0.01% | -30.8% |
| Q2 2019 | $1,578,000 | -23.1% | 38,235 | -24.7% | 0.01% | -23.5% |
| Q1 2019 | $2,052,000 | +26.0% | 50,744 | +18.4% | 0.02% | +21.4% |
| Q4 2018 | $1,628,000 | -31.1% | 42,875 | -28.2% | 0.01% | -6.7% |
| Q3 2018 | $2,364,000 | +13.8% | 59,751 | +1.0% | 0.02% | +7.1% |
| Q2 2018 | $2,077,000 | +1.2% | 59,141 | +0.8% | 0.01% | +180.0% |
| Q1 2018 | $2,052,000 | -60.5% | 58,689 | -60.8% | 0.01% | -58.3% |
| Q4 2017 | $5,196,000 | -12.5% | 149,720 | -14.6% | 0.01% | -14.3% |
| Q3 2017 | $5,939,000 | +75.1% | 175,297 | +76.2% | 0.01% | +55.6% |
| Q2 2017 | $3,392,000 | -42.2% | 99,487 | -47.2% | 0.01% | -43.8% |
| Q1 2017 | $5,871,000 | +116.7% | 188,536 | +90.2% | 0.02% | +100.0% |
| Q4 2016 | $2,709,000 | -55.5% | 99,148 | -46.5% | 0.01% | -57.9% |
| Q3 2016 | $6,085,000 | +2.9% | 185,155 | -5.4% | 0.02% | 0.0% |
| Q2 2016 | $5,911,000 | +10.2% | 195,800 | +2.8% | 0.02% | +11.8% |
| Q1 2016 | $5,363,000 | -30.4% | 190,470 | -16.1% | 0.02% | -22.7% |
| Q4 2015 | $7,707,000 | -31.7% | 227,076 | -36.0% | 0.02% | -37.1% |
| Q3 2015 | $11,289,000 | -46.0% | 354,757 | +8.1% | 0.04% | -32.7% |
| Q2 2015 | $20,900,000 | -26.4% | 328,040 | -21.0% | 0.05% | -22.4% |
| Q1 2015 | $28,396,000 | -8.5% | 414,997 | -5.8% | 0.07% | -14.1% |
| Q4 2014 | $31,021,000 | -19.8% | 440,734 | -18.6% | 0.08% | -16.1% |
| Q3 2014 | $38,689,000 | +16.8% | 541,537 | +21.5% | 0.09% | +10.7% |
| Q2 2014 | $33,123,000 | +30.8% | 445,752 | +14.2% | 0.08% | +16.7% |
| Q1 2014 | $25,319,000 | -19.6% | 390,231 | -26.5% | 0.07% | -25.0% |
| Q4 2013 | $31,504,000 | +31.7% | 530,619 | +15.2% | 0.10% | +11.6% |
| Q3 2013 | $23,919,000 | +20.6% | 460,614 | +9.9% | 0.09% | +3.6% |
| Q2 2013 | $19,835,000 | – | 419,291 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
| Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
| Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
| SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
| Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
| ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
| Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
| Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
| GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |